Center for Reproductive Medicine, Shandong University, Jinan, 250012, Shandong, China.
Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, 250012, Shandong, China.
Reprod Sci. 2023 Jul;30(7):2302-2312. doi: 10.1007/s43032-023-01177-0. Epub 2023 Feb 3.
This study was to determine whether multiple vitrification-warming procedures and insemination method are associated with pregnancy and neonatal outcomes in preimplantation genetic testing for aneuploidy (PGT-A). This was a retrospective, single-center, observational study of 112 patients who underwent standard PGT-A practice and 154 patients who desired PGT-A for their vitrified unbiopsied blastocysts. A total of 97 euploid blastocysts biopsied and vitrified-warmed once and 117 euploid blastocysts biopsied once but vitrified-warmed twice (83 in vitro fertilization [IVF]-derived and 34 intracytoplasmic sperm injection [ICSI]-derived euploid blastocysts) were transferred. The primary outcome was the blastocyst survival rate for transfer, live birth rate, and neonatal outcomes. The results showed that an additional vitrification-warming procedure on blastocysts resulted in a lower but not statistically different survival rate for transfer. Compared with euploid blastocysts vitrified-warmed once, those vitrified-warmed twice provided statistically similar live birth rate. Neonatal outcomes, including the sex ratio, gestational age, birthweight, preterm birth rate, and low birthweight rate, did not differ between single and double vitrification. No significant differences were observed in rates of blastocyst survival, blastocyst euploid and live birth, and neonatal outcomes resulting from either conventional IVF or ICSI. The neonatal follow-up of babies live-born so far did not report any congenital malformations. In conclusion, an additional vitrification-warming on blastocysts had no detectable adverse impact on clinical outcomes after frozen-thawed single euploid blastocyst transfer in PGT-A cases; and ICSI did not confer any benefit in improving clinical outcomes compared with conventional IVF in cases requiring PGT-A on already vitrified nonbiopsied blastocysts.
这项研究旨在确定多次玻璃化冷冻-解冻程序和授精方法是否与植入前遗传学检测(PGT-A)的胚胎妊娠和新生儿结局有关。这是一项回顾性、单中心、观察性研究,纳入了 112 名接受标准 PGT-A 治疗的患者和 154 名希望对其已冷冻的未活检囊胚进行 PGT-A 的患者。共对 97 枚整倍体囊胚进行活检和玻璃化冷冻-解冻 1 次,对 117 枚整倍体囊胚进行活检但玻璃化冷冻-解冻 2 次(83 枚来自体外受精 [IVF],34 枚来自胞浆内单精子注射 [ICSI])。主要结局是移植的囊胚存活率、活产率和新生儿结局。结果显示,囊胚的额外玻璃化冷冻-解冻程序导致的移植存活率降低,但无统计学差异。与单玻璃化冷冻-解冻的整倍体囊胚相比,双玻璃化冷冻-解冻的囊胚活产率统计学上相似。性别比、胎龄、出生体重、早产率和低出生体重率等新生儿结局在单次和双次玻璃化冷冻中无差异。无论是常规 IVF 还是 ICSI,囊胚存活率、囊胚整倍体率和活产率以及新生儿结局均无显著差异。迄今为止,通过冷冻解冻单个整倍体囊胚移植后,活产婴儿的新生儿随访未报告任何先天性畸形。总之,在 PGT-A 病例中,冷冻解冻单个整倍体囊胚后,囊胚的额外玻璃化冷冻-解冻对临床结局无明显不良影响;在需要对已冷冻的未活检囊胚进行 PGT-A 的情况下,与常规 IVF 相比,ICSI 并不能改善临床结局。